Cargando…

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

Objectives To reanalyse SmithKline Beecham’s Study 329 (published by Keller and colleagues in 2001), the primary objective of which was to compare the efficacy and safety of paroxetine and imipramine with placebo in the treatment of adolescents with unipolar major depression. The reanalysis under th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Noury, Joanna, Nardo, John M, Healy, David, Jureidini, Jon, Raven, Melissa, Tufanaru, Catalin, Abi-Jaoude, Elia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572084/ https://www.ncbi.nlm.nih.gov/pubmed/26376805 http://dx.doi.org/10.1136/bmj.h4320

Ejemplares similares

Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
por: Le Noury, Joanna, et al.
Publicado: (2016)

Antidepressant Prescribing and Suicide/Self-Harm by Young Australians: Regulatory Warnings, Contradictory Advice, and Long-Term Trends
por: Whitely, Martin, et al.
Publicado: (2020)

CARDIOGENIC SHOCK WITH IMIPRAMINE
por: Chaudhury, S., et al.
Publicado: (1990)

A DOUBLE-BLIND EVALUATION OF ALPRAZOLAM AND IMIPRAMINE IN THE TREATMENT OF MAJOR DEPRESSION
por: Murthy, R.S., et al.
Publicado: (1991)

TREATMENT BY IMIPRAMINE OF DEAFNESS AND DEPRESSION
por: Srivastava, V.K.
Publicado: (1998)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Health Tract No. 329: Writing
Publicado: (1868)

Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression
por: Shahsavand Ananloo, Esmaeil, et al.
Publicado: (2013)

IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
por: Dua, Dinesh, et al.
Publicado: (1990)

Granulomatous drug eruption associated with imipramine
por: Pascucci, Anabella
Publicado: (2018)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Repeated administration of imipramine modifies GABAergic transmission in rat frontal cortex
por: Wabno, Joanna, et al.
Publicado: (2012)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Annual Research Review: Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: a systematic review
por: Whitely, Martin, et al.
Publicado: (2018)

A COMPARATIVE EVALUATION OF DOTHIEPIN (PROTHIEDEN) AND IMIPRAMINE
por: Chaturvedi, M. K., et al.
Publicado: (1980)

Accelerated antidepressant response to lithium augmentation of imipramine
por: Saini, Rajiv, et al.
Publicado: (2016)

The next psychoactive drugs: From imipramine to ketamine
por: Carrillo, Pablo, et al.
Publicado: (2020)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima, Kunitoshi, et al.
Publicado: (2013)

White Matter Microstructure Alterations Associated With Paroxetine Treatment Response in Major Depression
por: Vieira, Rita, et al.
Publicado: (2021)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Paroxetine overdose during pregnancy
por: Acar, Selin, et al.
Publicado: (2021)

Health Canada: optimizing transparency and its impact for patients
por: Abi-Jaoude, Elia, et al.
Publicado: (2021)

Simultaneous Spectrophotometric Estimation of Imipramine Hydrochloride and Chlordiazepoxide in Tablets
por: Patel, Sejal, et al.
Publicado: (2009)

EFFECT OF IMIPRAMINE AND ECT ON PLATELET MAO ACTIVITY IN DEPRESSIVES
por: Trivedi, J.K., et al.
Publicado: (1989)

A COMPARATIVE STUDY OF DOTHIEPIN (PROTHIADEN) AND IMIPRAMINE IN DEPRESSION
por: Vyas, J.N., et al.
Publicado: (1989)

MULTICENTRIC EFFICACY STUDY OF CENTPROPAZINE AND IMIPRAMINE IN DEPRESSED PATIENTS
por: Srivastava, J.S., et al.
Publicado: (1999)

The effect of imipramine, ketamine, and zinc in the mouse model of depression
por: Wróbel, Andrzej, et al.
Publicado: (2015)

RP-HPLC Estimation of Imipramine Hydrochloride and Diazepam in Tablets
por: Srikantha, D., et al.
Publicado: (2015)

Imipramine blocks acute silicosis in a mouse model
por: Biswas, Rupa, et al.
Publicado: (2017)

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
por: Li, Zesheng, et al.
Publicado: (2023)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki, Akiko, et al.
Publicado: (2014)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Publicado: (2013)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi, Taro, et al.
Publicado: (2017)

Restoration of Serotonin Neuronal Firing Following Long-Term Administration of Bupropion but Not Paroxetine in Olfactory Bulbectomized Rats
por: Mansari, Mostafa El, et al.
Publicado: (2015)

Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex
por: Aree, Thammarat
Publicado: (2022)

THU329 Healthcare Disparities In Diabetes Management During The COVID-19 Pandemic
por: Frontera, Eric D, et al.
Publicado: (2023)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7a9sn17i3vbvtljpbgpr0b3v0r